Cipro (Ciprofloxacin Hydrochloride) for Inhalation Anthrax
Cipro (ciprofloxacin hydrochloride) is an antibiotic used to treat bacterial infections in many different parts of the body. It does not work for viral infections (for example, the common cold). Cipro is approved for the inhaled form of anthrax after an individual has been exposed. Safety and effectiveness in pediatric patients and adolescents less than 18 years of age have not been established, except for use in inhalational anthrax (post-exposure).
Cyber Letters to Web Sites Selling Cipro (11/1/2001)
Search the National Library of Medicine's PubMed database for journal references on Cipro.
This link automatically searches the PubMed database for reference to articles from medical journals.
Questions and Answers about Anthrax Prevention and Treatment from the Department of Health and Human Services
Information on Anthrax from the National Library of Medicine's MedlinePlus. Selected links to consumer information about anthrax.
- Antibiotic Resistance. Disease-causing microbes that have become resistant to drug therapy are an increasing public health problem. Tuberculosis, gonorrhea, malaria, and childhood ear infections are just a few of the diseases that have become hard to treat with antibiotic drugs. Part of the problem is that bacteria and other microorganisms that cause infections are remarkably resilient and can develop ways to survive drugs meant to kill or weaken them. This antibiotic resistance, also known as antimicrobial resistance or drug resistance, is due largely to the increasing use of antibiotics.
For more information about Cipro, please contact the Division of Drug Information at firstname.lastname@example.org or 1-888-INFOFDA (463-6332).